tirzepatide fda approval for weight loss Day 4: Zepbound (Tirzepatide – indication) Approved: November 2023 weight management Weight Loss: Up to 22.5% in clinical trials Similar to Mounjaro, but marketed specifically for weight management Introducing Tirzepatide NOW AVAILABLE at

At the highest dosage tier (15 mg), expect to pay around $387.98 per month on the standard monthly plan

Can Blurred Vision From Ozempic Be Reversed

By mimicking GLP-1 and GIP hormones, it helps manage blood sugar and suppress appetite, leading to substantial weight loss for many patients

Why Patients Choose Tirzepatide Over Semaglutide Patients who plateau on semaglutide sometimes experience renewed weight loss momentum after switching to tirzepatide, a phenomenon partly explained by the additional GIP receptor stimulation

The dual agonist nature of tirzepatide, acting on both GIP and GLP-1 receptors, contributes to its efficacy in glycaemic control and weight management but also influences the gastrointestinal side effect profile